I-chang C. Hsieh

Linkou Branch
Taoyuan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 172 publications

Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study).

Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study).

Journal: Journal of the American Heart Association

Published: May 14, 2026

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

Journal: Annals of medicine

Published: April 10, 2026

From 360° Cap Hunting to a Targeted Arc: IVUS-Angio Co-Registration for Ambiguous CTO Entry.

From 360° Cap Hunting to a Targeted Arc: IVUS-Angio Co-Registration for Ambiguous CTO Entry.

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: March 05, 2026

2026 Expert Consensus Recommendations on Hypertrophic Cardiomyopathy: A Report of the Task Force of the Taiwan Society of Cardiology.

2026 Expert Consensus Recommendations on Hypertrophic Cardiomyopathy: A Report of the Task Force of the Taiwan Society of Cardiology.

Journal: Acta Cardiologica Sinica

Published: February 25, 2026

2026 Consensus and review of Lipoprotein(a) from Taiwan Society of Lipid and Atherosclerosis: Molecular pathogenesis, epidemiology, clinical implications, and advances in diagnostic strategies.

2026 Consensus and review of Lipoprotein(a) from Taiwan Society of Lipid and Atherosclerosis: Molecular pathogenesis, epidemiology, clinical implications, and advances in diagnostic strategies.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: January 15, 2026

Human iPSC-EV-loaded nanofiber stent coatings accelerate vascular repair by enhancing EGFR/HIF-1α signaling and suppressing ROCK1-mediated remodeling.

Human iPSC-EV-loaded nanofiber stent coatings accelerate vascular repair by enhancing EGFR/HIF-1α signaling and suppressing ROCK1-mediated remodeling.

Journal: Materials today. Bio

Published: January 01, 2026

Epigenetic Signature of the Metastable Epiallele VTRNA2-1: Adipose Dysfunction and Suboptimal Bariatric Outcomes.

Epigenetic Signature of the Metastable Epiallele VTRNA2-1: Adipose Dysfunction and Suboptimal Bariatric Outcomes.

Journal: Obesity (Silver Spring, Md.)

Published: November 18, 2025

Taiwan Society of Cardiology: past, present, and future.

Taiwan Society of Cardiology: past, present, and future.

Journal: European heart journal

Published: September 26, 2025

Hypomethylation of VTRNA2-1 promoter predicts adverse outcomes in peripheral artery disease.

Hypomethylation of VTRNA2-1 promoter predicts adverse outcomes in peripheral artery disease.

Journal: Clinical epigenetics

Published: September 13, 2025

Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome and Chronic Kidney Disease: A Real-World Analysis from a National Registry.

Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome and Chronic Kidney Disease: A Real-World Analysis from a National Registry.

Journal: Medicina (Kaunas, Lithuania)

Published: September 03, 2025

Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan.

Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan.

Journal: Journal of cancer research and clinical oncology

Published: August 07, 2025

Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning.

Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning.

Journal: Cancers

Published: May 19, 2025

Showing 1-12 of 172

Last Updated: 09/26/2026